Read Larry Connors' blog – Short Term Trading Strategies
This report is an essential source for in-depth information and data relating to Australia neurology devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the neurology devices in Australia.
Scope
The report provides neurology devices information broken down into detailed categories and segments in Australia. Total revenues, products sold, end users, and average pricing. Market shares of all the key competitors. Key pipeline products that are set to shape the market, broken down by sector. Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information. Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement. Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes. Key mergers and acquisitions, partnerships, private equity investments and IPOs. Customer, hospitals and physicians data.
Reasons to buy
Gain a strong understanding of the neurology devices market in Australia. Evaluate and compare the attractiveness of the market in the country. Identify growth segments and opportunities in each industry sector within the country. Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country. Analyze the competitiveness of the market in the country and identify hotspots. Develop strategies based on the latest product, brand, expansion and research and development news in the country. Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country. Identify and analyze the strengths and weaknesses of the industry incumbents in the country.
Key Topics Covered:
1 Executive Summary 2 Introduction 3 Definitions of Markets Covered in the Report 4 Healthcare Sector Review 5 Regulation System 6 Pricing and Reimbursement 7 Distribution Structure 8 Neurology Devices In Australia 9 CSF Management In Australia 10 Interventional Neurology In Australia 11 Neurostimulation Devices In Australia 12 Neurosurgical Products (Neuroendoscopes) In Australia 13 Radiosurgery In Australia 14 Medtronic, Inc. Company Profile 15 Boston Scientific Corporation Company Profile 16 Cyberonics, Inc. Company Profile 17 Cordis Corporation Company Profile 18 ev3 Inc. Company Profile 19 Codman & Shurtleff, Inc. Company Profile 20 Acuhealth Pty Ltd Company Profile 21 Compumedics Limited Company Profile 22 Med-Chem Surgical Pty Ltd Company Profile 23 Appendix List of Figures
For more information visit http://www.researchandmarkets.com/research/85658b/australia_neurolog.
SOURCE: Research and Markets
Research and Markets Laura Wood Senior Manager press@researchandmarkets.com Fax from USA: 646-607-1907 Fax from rest of the world: +353-1-481-1716
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.
It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.
HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.
The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302
© Copyright 2009 The Connors Group, Inc.
